WELD CAPITAL MANAGEMENT LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELD CAPITAL MANAGEMENT LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2020$529,000
-69.2%
5,902
-65.7%
0.21%
-76.3%
Q1 2020$1,717,000
+466.7%
17,224
+584.9%
0.88%
+1462.5%
Q2 2019$303,000
-51.9%
2,515
-60.1%
0.06%
-60.6%
Q4 2018$630,0006,2960.14%
Other shareholders
HAEMONETICS CORP shareholders Q3 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders